Omega Healthcare Investors logo
Omega Healthcare Investors OHI
$ 44.49 1.21%

Quarterly report 2025-Q3
added 10-31-2025

report update icon

Omega Healthcare Investors Financial Statements 2011-2025 | OHI

Annual Financial Statements Omega Healthcare Investors

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

9.38 B 7.42 B 6.63 B 7.12 B 7.46 B 8.96 B 7.94 B 5.19 B 6.08 B 5.46 B 5.55 B 3.7 B 2.75 B 2.14 B

Shares

258 M 240 M 236 M 237 M 228 M 213 M 200 M 198 M 192 M 172 M 127 M 117 M 108 M 102 M

Historical Prices

36.3 30.9 28.1 30 32.8 34.9 31.2 19.2 21 19.3 25.3 17.4 13.1 9.71

Net Income

418 M 249 M 439 M 428 M 164 M 341 M 282 M 100 M 366 M 225 M 221 M 173 M 121 M 52.6 M

Revenue

1.05 B 950 M 878 M 1.06 B 892 M 929 M 882 M 908 M 901 M 744 M 505 M 419 M 350 M 292 M

Gross Profit

- - - - - 914 M - - - - - - - 292 M

Operating Income

- - - - - 552 M 498 M 315 M 560 M 411 M 345 M 266 M 215 M 138 M

Interest Expense

18.2 M 99.5 M 358 M 130 M 4.89 M 56.5 M 192 M 189 M 164 M 147 M 119 M 100 M 95.5 M 81.2 M

EBITDA

305 M 320 M 332 M 342 M 330 M 856 M 811 M 846 M 845 M 697 M 476 M 395 M 329 M 266 M

Operating Expenses

649 M 794 M 800 M 777 M 735 M 360 M 351 M 350 M - - - - - 126 M

General and Administrative Expenses

88 M 81.5 M 69.4 M 64.6 M 59.9 M 57.9 M 63.5 M 47.7 M 45.9 M 38.6 M 25.9 M 21.6 M 21.3 M 19.4 M

All numbers in USD currency

Quarterly Income Statement Omega Healthcare Investors

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

296 M 291 M 283 M 279 M 263 M 249 M 246 M 245 M 245 M 236 M 235 M 234 M 235 M 236 M 240 M 239 M 239 M 236 M 233 M 231 M 228 M 227 M 227 M 227 M 218 M 212 M 205 M 202 M 201 M 199 M 199 M 198 M 198 M 197 M 197 M 196 M 194 M 189 M 188 M 187 M 185 K 183 K 134 M 128 M 127 M 126 M 124 M 124 M 118 M 116 M 113 M 112 M 109 M 106 M 104 M 103 M 103 M 102 M 100 M

Net Income

180 M 137 M 109 M - 112 M 114 M 67.4 M - 93.9 M 61.5 M 36.8 M - 105 M 91.9 M 195 M - 143 M 86.9 M 164 M - -93.8 M 102 M 92.3 M 61.1 M 143 M 75.7 M 72.2 M 64.9 M 59.1 M 82 M 87.9 M 65.2 M -138 M 68.2 M 109 M 124 M 78.5 M 108 M 55.6 M 63.5 M 79.4 M 41.4 M 43.1 M 57 M 61.7 M 46.8 M 55.8 M 47.2 M 38.1 M 49.1 M 38.1 M 33.9 M 30.1 M 30.6 M 26.1 M 19.3 M 21.4 M 17.8 M -5.91 M

Revenue

312 M 283 M 277 M - 276 M 253 M 243 M - 242 M 250 M 218 M - 239 M 245 M 249 M - 282 M 257 M 274 M - 119 M 256 M 253 M 247 M 233 M 225 M 224 M 220 M 222 M 220 M 220 M 221 M 220 M 236 M 232 M - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - - - - - - - - - - - - -39.5 M 157 M 148 M - 187 M 127 M 122 M - 111 M 133 M 138 M - -88.2 M 141 M 139 M - 124 M 142 M 96.5 M - 126 M 74.3 M 85.9 M - 92.2 M 79.8 M 83 M - 63.3 M 64.7 M 64.5 M - 53.1 M 51.6 M 51.5 M - 43.4 M 38.6 M 14.8 M

Interest Expense

45.1 M 36.6 M 13.1 M - -1.42 M 16.1 M 2.6 M - 49.5 M 13.3 M 16.4 M - 40.4 M 20.8 M 113 M - 54.8 M 4.27 M 70.9 M - -1.71 M 13 M 1.03 M - -52.2 M -51 M 48.1 M - 47.8 M 48.1 M 48 M - 47.4 M 48.1 M 45 M - 42.9 M 39.7 M 37.2 M - 38.2 M 38.2 M 32.4 M - 30.9 M 29.4 M 27.1 M - 24.5 M 25 M 25.7 M - 24 M 24 M 23 M - 20.1 M 20.1 M 20 M

EBITDA

- - - - - - - - - - - - 82.7 M 83.2 M 82.8 M - 86.1 M 85.8 M 84.8 M - 41.6 M 240 M 230 M - 264 M 200 M 193 M - 181 M 202 M 208 M - -16.3 M 211 M 209 M - 193 M 208 M 159 M - 186 M 133 M 117 M - 122 M 111 M 114 M - 95.5 M 97 M 96.4 M - 81.5 M 78.8 M 78.6 M - 68.3 M 63.3 M 40 M

Operating Expenses

165 M 172 M 175 M - 163 M 150 M 174 M - 194 M 201 M 200 M - 178 M 174 M 168 M - 194 M 175 M 191 M - 212 M 168 M 162 M - 99.1 M 98.5 M 102 M - 106 M 84.3 M 99.6 M - 308 M 94.7 M 92.5 M - 100 M 86.6 M 116 M - 75.9 M 123 M 47.5 M - 38.4 M 42 M 38 M - 40 M 37.8 M 37.3 M - 34 M 32.3 M 33 M - 29.4 M 34.1 M 55.7 M

General and Administrative Expenses

23.8 M 23.8 M 32.1 M - 21.8 M 22.1 M 21.5 M - 20.3 M 22.2 M 20.5 M - 18.2 M 18.8 M 16.4 M - 15.4 M 15.2 M 16.2 M - 14.8 M 14 M 15.9 M - 13.8 M 13.9 M 16.1 M - 14.2 M 15.2 M 16.5 M - 11.6 M 11.5 M 12.5 M - 12.4 M 11.8 M 10.5 M - 10.2 M 10.3 M 6.01 M - 5.99 M 6.3 M 6.5 M - 5.46 M 5.48 M 5.2 M - 5.17 M 4.95 M 5.53 M - 4.39 M 4.93 M 5.23 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Omega Healthcare Investors OHI
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Omega Healthcare Investors plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Reit healthcare industry

Issuer Price % 24h Market Cap Country
The GEO Group The GEO Group
GEO
$ 16.54 -1.69 % $ 2.17 B usaUSA
LTC Properties LTC Properties
LTC
$ 35.03 0.89 % $ 1.53 B usaUSA
Global Medical REIT Global Medical REIT
GMRE
$ 35.3 0.57 % $ 2.33 B usaUSA
National Health Investors National Health Investors
NHI
$ 78.1 0.97 % $ 3.42 B usaUSA
Healthpeak Properties Healthpeak Properties
PEAK
- 2.09 % $ 9.35 B usaUSA
Ventas Ventas
VTR
$ 78.8 1.19 % $ 32.4 B usaUSA
Welltower Welltower
WELL
$ 190.7 2.13 % $ 115 B usaUSA
Sabra Health Care REIT Sabra Health Care REIT
SBRA
$ 19.18 0.03 % $ 4.48 B usaUSA